2013. ISPOR European Congress – Validation of ACCEPT®, A New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-Life

Arnould B, Gauchoux R, Meunier J, Gilet H, Regnault A. Validation of ACCEPT®, A New Generic Measure to Assess How Patients with Chronic Diseases Balance Between the Advantages and Disadvantages of Following the Recommended Treatment Regimen in Real-Life. Value Health. 2013 Nov;16(7):A335. Presented at: ISPOR 16th Annual European Congress; November 2, 2013; Dublin, Ireland.